Cognito Therapeutics, Inc.

Cognito, a company based in Cambridge, MA, is developing disease-modifying treatments to revive the health and well-being of patients living with Alzheimer's. With approximately 11 employees, Cognito is advancing a new approach to Alzheimer's treatment by targeting the abnormal neuronal activity observed in patients, with promising results from their phase 2 clinical studies.